Spondyloarthritis: May the force be with you?

Annals of the Rheumatic Diseases

Volumn 73, Issue 2, 2014, Pages 321-323

  McGonagle, Dennis ^a,b   Thomas, Rebecca C ^a   Schett, Georg ^c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b CHAPEL ALLERTON HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; HLA B27 ANTIGEN; INTERLEUKIN 23; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ADAPTIVE IMMUNITY; ARTHRITIS; ARTICLE; AUTOIMMUNITY; BIOMECHANICS; BONE EROSION; BONE STRESS; ENTHESITIS; EXERCISE; GENETIC ASSOCIATION; HEREDITY; HUMAN; JOINT FUNCTION; MECHANICAL STRESS; MEDICAL RESEARCH; MUSCLE STRESS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPONDYLARTHRITIS; SYNOVITIS;

EID: 84891748263     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203924     Document Type: Article

References (26)

1. Jacques P, Lambrecht S, Verheugen E, et al. Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells. Ann Rheum Dis 2014;73:437-45.
2. Schlosstein L, Terasaki PI, Bluestone R, et al. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973;288:704-6.
3. La Cava G. Enthesitis; traumatic disease of insertions. J Am Med Assoc 1959;169:254-5.
4. Wright V. Psoriatic arthritis. In: Scott J, ed. Copeman's textbook of the rheumatic diseases. 5th edn. Edinburgh: Churchill Livingstone, 1978:537-48.
5. Moll JM, Wright V. Familial occurrence of psoriatic arthritis. Ann Rheum Dis 1973;32:181-201.
6. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973;3:55-78.
7. Rich P, Griffiths CE, Reich K, et al. Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J Am Acad Dermatol 2008;58:224-31.
8. Bywaters E. Pathology of spondyloarthropathies. In: Calin A, ed. Spondyloarthropathies. London: Grune and Stratton; 1984:43-68.
9. McGonagle D, Stockwin L, Isaacs J, et al. An enthesitis based model for the pathogenesis of spondyloarthropathy. additive effects of microbial adjuvant and biomechanical factors at disease sites. J Rheumatol 2001;28:2155-9. (Pubitemid 32947855)
10. Benjamin M, McGonagle D. The enthesis organ concept and its relevance to the spondyloarthropathies. Adv Exp Med Biol 2009;649:57-70.
11. Jacques P, Venken K, Van Beneden K, et al. Invariant natural killer T cells are natural regulators of murine spondyloarthritis. Arthritis Rheum 2010;62:988-99.
12. Diarra D, Stolina M, Polzer K, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007;13:156-63.
13. Correa-Meyer E, Pesce L, Guerrero C, et al. Cyclic stretch activates ERK1/2 via G proteins and EGFR in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2002;282:L883-91. (Pubitemid 34654602)
14. Cornelissen J, Armstrong J, Holt CM. Mechanical stretch induces phosphorylation of p38-MAPK and apoptosis in human saphenous vein. Arterioscler Thromb Vasc Biol 2004;24:451-6. (Pubitemid 38326137)
15. Papakrivopoulou J, Lindahl GE, Bishop JE, et al. Differential roles of extracellular signal-regulated kinase 1/2 and p38MAPK in mechanical loadinduced procollagen alpha1 (I) gene expression in cardiac fibroblasts. Cardiovasc Res 2004;61:736-44. (Pubitemid 38249472)
16. Lal H, Verma SK, Smith M, et al. Stretch-induced MAP kinase activation in cardiac myocytes: differential regulation through beta1-integrin and focal adhesion kinase. J Mol Cell Cardiol 2007;43:137-47. (Pubitemid 47069384)
17. Sherlock JP, Joyce-Shaikh B, Turner SP, et al. IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8-entheseal resident T cells. Nat Med 2012;18:1069-76.
18. Thomas GP, Brown MA. Genomics of ankylosing spondylitis. Discov Med 2010;10:263-71.
19. Castillo-Gallego C, Aydin SZ, Emery P, et al. Brief report: magnetic resonance imaging assessment of axial psoriatic arthritis: extent of disease relates to HLA-B27. Arthritis Rheum 2013;65:2274-8.
20. Maksymowych WP. Ankylosing spondylitis-at the interface of bone and cartilage. J Rheumatol 2000;27:2295-301.
21. Lories RJ, Derese I, Luyten FP. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest 2005;115:1571-9. (Pubitemid 40814665)
22. Lience E, Ros C, Sellas A, et al. Rheumatoid arthritis and hemiplegia: remission of the arthritis in the paretic limbs and appearance of a subcutaneous nodule in the non paretic elbow. Med Clin 1993;101:518-9.
23. Smith RD. Effect of hemiparesis on rheumatoid arthritis. Arthritis Rheum 1979;22:1419-20.
24. Braun J, Van Den Berg R, Baraliakos X, et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2011;70:896-904.
25. Ward MM, Reveille JD, Learch TJ, et al. Occupational physical activities and long-term functional and radiographic outcomes in patients with ankylosing spondylitis. Arthritis Rheum 2008;59:822-32. (Pubitemid 351847565)
26. Armaka M, Apostolaki M, Jacques P, et al. Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases. J Exp Med 2008;205:331-7. (Pubitemid 351281599)